TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Estimated Percentage Change in Fasting Triglyceride(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Behavior of the children during the dental injection
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6 Month Progression-Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Tolerance of 2000 mg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of cat scratch colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Class A healing rate of the surgical incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time-weighted average SaO2/FiO2 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent of Self-Test Fingerstick Blood Glucose Results Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Receipt of Preventive Care Services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Emergency Department Utilization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Grip strength assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of BG9928
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall safety and tolerability assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetic analysis of KX2-391
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: differences in immune function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Movement of the Bladder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pain measurement using CHEOPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive predictive value (PPV) of HFRS High Risk Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Spinal Cord Independence Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Highest grade of central nervous system (CNS) necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of occurrence of a recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Standardized Uptake Value (SUV) for 18F-Fluoride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number, severity, and type of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Overall clearance of lambda FLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall albumin loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Glucose Monitoring System Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in DNA Integrity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Bupropion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Time 0 to the Last Quantifiable Concentration (AUCt) of Bupropion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Time 0 to Infinity (AUCinf) of Bupropion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Mesh Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of IgG anti-Hib (ug/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline of specific IgG against pneumococcal serotypes 4, 6B, 9V, 14, 18C, 19F and 23F (ug/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with unacceptable toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Ct Value from PCR Reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Self-reported physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants in the program at the end of the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vegetable plate waste
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in tobacco susceptibility at 24 hours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in tobacco susceptibility at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Use of pain-related services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient satisfaction with health care services
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximal Effect Score (Emax) of Bipolar Drug Liking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving a complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients developing a side effect
Endpoint domain: Adverse events/effects
Primary endpoint: Body weight, percent change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intimal thickness in the coronary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transplantation-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Oculocardiac reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum anti-Mullerian hormone (AMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in PANSS Positive Subscale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Symptom Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifespan of the PNNs
Endpoint domain: Mortality/survival
Primary endpoint: Combined cardiovascular end-point events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cognitive Processing Therapy Fidelity Ratings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity and Specificity of the HPV integration screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tobacco-cessation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of 11C Choline PET Imaging Scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of 11C Choline PET Imaging Scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of Participants With Positive or Negative PET, CT, or MRI Modalities Resulting in Prostate Cancer (PCa) Confirmation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Titers of maternal pertussis specific antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in response time during a novel motor task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wolf Motor Function Task Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of death or serious complications
Endpoint domain: Mortality/survival
Primary endpoint: Ki67 expression in breast tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in overall severity rated on 3-point scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reduction in breathlessness rated on a 4-point scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global assessment of efficacy by the patients rated on 5-point scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distribution of patients across the ordinal modified Rankin scale (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensory recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Device Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum infliximab level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients treated effectively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in symptoms of psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival of Participants
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Ocular Discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Posterior Lid Margin Hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic and local adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: stabilization time of critically ill patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Cycles With Ovulation Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: step length of affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stride length of affected side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provider prescription rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Individual patient Anticoagulation (AC) status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 2-year Loco-regional Tumor Control Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline in the global Menopause Rating Scale (MRS) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Coronary artery outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in symptoms (MADRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms (YMRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in symptoms (CGI-BP-M)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relapse of violence
Endpoint domain: Adverse events/effects
Primary endpoint: Swallowing skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction at time of visit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utilization of health services at one year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health outcome at one year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MTD or recommended phase II dose
Endpoint domain: Physiological/clinical
Primary endpoint: Pharmacokinetics of IMC-A12
Endpoint domain: Physiological/clinical
Primary endpoint: Change in grade of fecal incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in grade of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in Cesarean section rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: flare value in the anterior chamber after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obsessive Compulsive Inventory-Revised score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of estimated Glomerular Filtration Rate (eGFR) decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of End Stage Renal Disease (ESRD)
Endpoint domain: Mortality/survival
Primary endpoint: Femoral Nerve Tension Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Manual muscle test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: successful MMR maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in EEG- and AEP-parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Negative Predictive Value of Lung Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knowledge, Attitude and Practice about cervix cancer and HPV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SARS-CoV-2 infection prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Recurrent rate of febrile seizures
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Gross Motor Function Measure Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive and Negative syndrome scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Pain Day 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Self-reported Parent-Child Relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of BAY3427080
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Observed Drug Concentration in Plasma (Tmax) of BAY3427080
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinity (AUC0-∞) of BAY3427080
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of CMR for predicting significant coronary artery stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery of organ function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phase shift between pulsations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase of 4mm or more in APRPD by ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Asthma Control as assessed by Childhood Asthma Control Test (cACT) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Asthma Control as assessed by Asthma Control Test (ACT) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with at least one asthma-related ED or urgent care visit during the six-month follow-up period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of Endometritis
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of Wound Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Activation of FXR-dependent genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety of recombinant plague vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Concentration Curve Over a 24 Hour Dosing Interval (AUCτ) of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Observed Drug Concentration (Cmin) of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of melatonin on GERD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of subjects who die
Endpoint domain: Mortality/survival
Primary endpoint: Polyps regression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to Pleural Catheter Removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevalence of fetal malformations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of Patients Achieving Disease Response Based on BVAS at Day 85
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum metabolomic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of data from GEx system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of data from GEx system
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of contrast volume quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bone growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in amplitude of N100-related waveforms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in concentration of glutamate-glutamine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in strength of resting-state-functional-connectivity among brain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in auditory verbal hallucination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from Peri-procedural major adverse events (PPMAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with premature myocardial contractions and/or atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Difference in SOFA Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite health care infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge, attitudes, and behaviors of trainees
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline in Acceptability of Intervention Measure (AIM) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Intervention Appropriateness Measure (IAM) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Feasibility of Intervention Measure (FIM) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in hematocrit levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: resolution of vasopressor-dependent hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite measure of participants not alive
Endpoint domain: Mortality/survival
Primary endpoint: Progression of AKI stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Durable Radiographic Response (DRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients completing modules
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: VAS recording of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tacrolimus concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of intestinal flora of stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: peak oxygen uptake at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak oxygen uptake at week 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Accurate NIBP Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of follow-up colonoscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of pneumococcal infection
Endpoint domain: Adverse events/effects
Primary endpoint: swelling of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Median Percent Change From Baseline in All Partial Seizure Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Specific Safety Parameters
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with an imaging-defined ischemic penumbra at admission that warrants revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of patients with successful revascularization of the occluded target vessel as defined by a TIMI score of 2 or 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with a modified Rankin Score (mRS) of ≤2 at 90 days post-procedure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Small bowel or rectal irritation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Bladder complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants Experiencing of Adverse or Hypersensitivity Reaction
Endpoint domain: Adverse events/effects